Dyslipidemia

• FDA approval · 2010-01-08
  FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Pravastatin Sodium (generic pravastatin) under the ANDA, authoriz…

• FDA approval · 2009-08-03
  FDA Approved: LIVALO — Original Application (Kowa Pharmaceuticals America, Inc.)

  FDA approved LIVALO (pitavastatin calcium) from Kowa Pharmaceuticals America, Inc. as an original NDA (NDA022363) for the treatment of hyper…

• FDA approval · 2009-01-08
  FDA Approved: VYTORIN — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for VYTORIN (ezetimibe/simvastatin) submitted by Organon LLC.

• FDA approval · 2007-03-16
  FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for pravastatin sodium submitted by Teva Pharmaceuticals USA, Inc. under ANDA 076056. The action rel…